You are here

Article Text

Article menu
Download PDFPDF
Lung alert
Higher mortality from non-small cell lung cancer reported in subjects treated with oestrogen and progestin
  1. P A Marsden
  1. Correspondence to P A Marsden, ST3 Respiratory Medicine, Blackpool Victoria Hospital, UK; Paul.A.Marsden{at}manchester.ac.uk

https://doi.org/10.1136/thx.2009.134809

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    The Women's Heath Initiative (WHI) trial was a double-blind randomised placebo-controlled trial that examined the health benefits and risks of combined oestrogen and progestin in 16 608 postmenopausal women in the USA. The study was stopped early as health risks were shown to exceed benefits. In this study, both the incidence and mortality from lung …

    View Full Text